In a patient presenting within 30 minutes with a large middle cerebral artery (MCA) stroke involving more than one-third of the territory and no standard exclusion criteria, is intravenous tissue plasminogen activator (tPA) contraindicated?

tPA is NOT contraindicated in this scenario when presenting within 3 hours

For a patient presenting within 30 minutes of a large MCA stroke involving more than one-third of the territory and no standard exclusion criteria, IV tPA should be administered immediately, as the benefit of treatment within 3 hours outweighs the risks, even with extensive early ischemic changes.

Key Evidence-Based Reasoning

Within 3-Hour Window: Early Ischemic Changes Are NOT an Absolute Contraindication

The 2018 AHA/ASA Guidelines explicitly state that IV alteplase is recommended in the setting of early ischemic changes on CT of mild to moderate extent (other than frank hypodensity) 1. The critical distinction here is:

• Mild-to-moderate hypoattenuation: tPA is indicated (Class I recommendation)
• Extensive regions of clear hypoattenuation/obvious hypodensity: Not recommended (represents irreversible injury) 1

The 3-Hour vs 3-4.5 Hour Window Distinction

This is where timing becomes crucial:

Within 0-3 hours:

• Severe stroke symptoms are an indication for tPA, not a contraindication 1
• Early ischemic changes involving >1/3 MCA territory are NOT listed as a contraindication
• The guidelines state: "Despite increased risk of hemorrhagic transformation, there is still proven clinical benefit for patients with severe stroke symptoms" 1

Within 3-4.5 hours:

• Imaging evidence of ischemic injury involving >1/3 MCA territory IS a contraindication 1
• This restriction only applies to the extended window

Supporting Evidence from Clinical Practice

A 2007 review specifically addressed this issue: **"Excluding patients with severe stroke or with early ischemic changes in more than one third of the middle cerebral artery territory on baseline CT scan is probably not necessary when treatment is started <3 hours of symptom onset"** 2. This reinforces that the >1/3 MCA territory restriction was primarily designed for the 3-4.5 hour window, not the 0-3 hour window.

Research data supports this approach. A 2016 study of patients with large MCA infarcts (NIHSS >15) treated with IV tPA showed:

• 39% favorable outcomes vs 17% without tPA (p<0.001)
• 16% mortality vs 51% without tPA (p<0.001)
• No significant difference in symptomatic ICH (6% vs 4%) 3

Clinical Algorithm for This Scenario

At 30 minutes from onset with large MCA stroke:

1. Confirm no standard exclusion criteria (hemorrhage on CT, coagulopathy, recent surgery, uncontrolled BP >185/110)
2. Assess CT findings:
   • Mild-to-moderate hypoattenuation → Proceed with tPA
   • Frank hypodensity/obvious severe hypoattenuation → Do not give tPA 1
3. Administer tPA immediately (0.9 mg/kg, max 90 mg)
4. Prepare for possible endovascular therapy if large vessel occlusion confirmed

Critical Pitfalls to Avoid

Do not confuse the 3-hour and 3-4.5 hour eligibility criteria. The >1/3 MCA territory restriction is specifically for the 3-4.5 hour window, along with other restrictions (age >80, diabetes + prior stroke, NIHSS >25, oral anticoagulants) 1. These do NOT apply within 3 hours.

Do not delay treatment to obtain advanced imaging. At 30 minutes from onset, every minute counts. Non-contrast CT to exclude hemorrhage is sufficient to proceed with tPA in this hyperacute timeframe.

Recognize that "extensive regions of clear hypoattenuation" means obvious hypodensity representing completed infarction 1, not subtle early ischemic changes that are commonly seen even in salvageable tissue.

Time-Dependent Benefit

The guidelines emphasize that "benefit of therapy is time dependent, and treatment should be initiated as quickly as possible" 1. At 30 minutes from onset, you are in the optimal treatment window where even patients with severe strokes and early ischemic changes derive substantial benefit from thrombolysis.